Meenu Chhabra Karson is a seasoned executive in the biopharmaceutical industry with extensive leadership experience across various companies. Currently serving as Chairperson at Harness Therapeutics and Executive Chair at Samsara Therapeutics since 2024 and 2023, respectively, Karson is also a Board Director at MacroGenics, Inc., and has previously held leadership roles including Chair of the Board of Directors at Apexigen and Board Member with Chair of Audit Committee responsibilities at Fore Biotherapeutics. Notable past positions include President & CEO at Proteostasis Therapeutics and ALLOZYNE, as well as Vice President of Business Development & Licensing at Novartis. Educational qualifications include an MBA in Strategy & Finance from the Schulich School of Business at York University and an Hons B.Sc in Pharmacology from the University of Toronto.